Related Experiment Videos
Amphiphilic block copolymers for drug delivery
Monica L Adams1, Afsaneh Lavasanifar, Glen S Kwon
1Division of Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI 53705-2222, USA.
Journal of Pharmaceutical Sciences
|June 24, 2003
Summary
Amphiphilic block copolymers (ABCs) form polymeric micelles for drug delivery. These structures enhance drug solubility, pharmacokinetics, and targeting, offering versatile pharmaceutical applications.
Area of Science:
- Polymer Chemistry
- Materials Science
- Pharmaceutical Sciences
Background:
- Amphiphilic block copolymers (ABCs) possess unique hydrophilic-polymers and hydrophobic-polymers structures.
- ABCs self-assemble in aqueous solutions into polymeric micelles with nanoscopic core/shell structures.
- These micelles are utilized for encapsulating hydrophobic drugs via various loading methods.
Purpose of the Study:
- To provide an introduction to the application of ABCs and polymeric micelles in drug delivery.
- To highlight the advantages of ABCs in pharmaceutical applications.
- To review current and past research in this field.
Main Methods:
- Review of existing literature on amphiphilic block copolymers and polymeric micelles.
- Analysis of the self-assembly behavior of ABCs in aqueous solutions.
- Discussion of drug loading strategies and pharmaceutical applications.
Main Results:
- ABCs form polymeric micelles above their critical micelle concentration.
- Hydrophobic drugs can be loaded into the hydrophobic core of the micelles.
- Various ABCs, including Pluronics and those with poly(L-amino acid) or poly(ester) blocks, show promise.
- ABCs offer benefits like prolonged circulation time, targeted delivery, and modified drug release.
Conclusions:
- Amphiphilic block copolymers and their self-assembled polymeric micelles are effective drug delivery systems.
- ABCs enable drug solubilization, stabilization, altered pharmacokinetics, and suppression of multidrug resistance.
- The choice of ABCs can be tailored for specific drug delivery requirements, optimizing therapeutic outcomes.